| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Indaptus Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 75K | Oct 9, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | Oct 9, 2024 | 1 | $0 | 4 | Oct 10, 2024 | Chief Operating Officer |
| INDP | Indaptus Therapeutics, Inc. | Jan 22, 2024 | 1 | $0 | 4 | Jan 23, 2024 | Chief Operating Officer |
| INDP | Indaptus Therapeutics, Inc. | Jan 18, 2023 | 1 | $0 | 4 | Jan 20, 2023 | Chief Business Officer |
| INDP | Indaptus Therapeutics, Inc. | Sep 7, 2022 | 1 | $393 | 4 | Sep 9, 2022 | Chief Business Officer |
| INDP | Indaptus Therapeutics, Inc. | Jan 26, 2022 | 1 | $0 | 4 | Jan 28, 2022 | Chief Business Officer |
| INDP | Indaptus Therapeutics, Inc. | Aug 4, 2021 | 1 | $0 | 4 | Aug 6, 2021 | Chief Business Officer |
| INDP | Intec Parent Inc. | Jul 23, 2021 | 0 | $0 | 3 | Aug 2, 2021 | Chief Business Officer |